141 related articles for article (PubMed ID: 25358722)
1. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas.
Takeda C; Takagi Y; Shiomi T; Nosaka K; Yamashita H; Osaki M; Endo K; Minamizaki T; Teshima R; Nagashima H; Umekita Y
Diagn Pathol; 2014 Oct; 9():205. PubMed ID: 25358722
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.
Takagi Y; Matsuoka Y; Shiomi T; Nosaka K; Takeda C; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Histopathology; 2015 Apr; 66(5):732-9. PubMed ID: 25322663
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic Maspin Expression Correlates with Poor Prognosis of Patients with Adenocarcinoma of the Uterine Cervix.
Nosaka K; Horie Y; Shiomi T; Itamochi H; Oishi T; Shimada M; Sato S; Sakabe T; Harada T; Umekita Y
Yonago Acta Med; 2015 Dec; 58(4):151-6. PubMed ID: 26740733
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic-only Expression of Maspin Predicts Unfavorable Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Uchinaka EI; Sakabe T; Hanaki T; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y; Umekita Y
Anticancer Res; 2021 May; 41(5):2543-2552. PubMed ID: 33952482
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
Kawasaki M; Sakabe T; Kodani I; Umekita Y
Anticancer Res; 2021 Sep; 41(9):4563-4570. PubMed ID: 34475084
[TBL] [Abstract][Full Text] [Related]
8. Expression of maspin predicts poor prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2002 Aug; 100(4):452-5. PubMed ID: 12115529
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer.
Acikalin D; Oner U; Can C; Acikalin MF; Colak E
Tumori; 2012; 98(3):344-50. PubMed ID: 22825520
[TBL] [Abstract][Full Text] [Related]
10. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
11. Maspin and Nm23-H1 expression in colorectal cancer.
Pasz-Walczak G; Salagacka A; Potemski P; Balcerczak E; Kordek R; Mirowski M
Neoplasma; 2010; 57(2):95-101. PubMed ID: 20099971
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.
Lu M; Li J; Huang Z; Du Y; Jin S; Wang J
Med Sci Monit; 2016 Jan; 22():134-9. PubMed ID: 26757744
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Berardi R; Santinelli A; Onofri A; Brunelli A; Pierantoni C; Pisa E; Pagliacci A; Stramazzotti D; Zuccatosta L; Mazzanti P; Sabbatini A; Gasparini S; Bearzi I; Cascinu S
Anal Quant Cytol Histol; 2012 Apr; 34(2):72-8. PubMed ID: 22611762
[TBL] [Abstract][Full Text] [Related]
16. Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.
Mhawech-Fauceglia P; Dulguerov P; Beck A; Bonet M; Allal AS
J Clin Pathol; 2007 Feb; 60(2):185-9. PubMed ID: 16698950
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
18. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
Sorbye SW; Kilvaer TK; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
PLoS One; 2012; 7(10):e47068. PubMed ID: 23071715
[TBL] [Abstract][Full Text] [Related]
20. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
